Clinical Features	Time to Death	AGE	GENDER	KARNOFSKY.PERFORMANCE.SCORE	PATHOLOGY.T	PATHOLOGY.N	PATHOLOGICSPREAD(M)	TUMOR.STAGE	NEOADJUVANT.THERAPY
Statistical Tests	logrank test	ANOVA	Fisher's exact test	ANOVA	Chi-square test	Fisher's exact test	Fisher's exact test	Chi-square test	Fisher's exact test
mRNA CNMF subtypes	0.0868	0.795	0.634		0.00911	0.0704	0.12	0.0134	0.194
mRNA cHierClus subtypes	0.189	0.607	0.82		0.00779	0.124	0.0988	0.0102	0.208
CN CNMF	1.14e-05	0.0703	0.0383	0.888	0.00254	0.0122	0.000525	0.00253	0.735
METHLYATION CNMF	9.14e-08	0.0456	0.0262	0.647	8.27e-11	0.0718	9.62e-05	2.15e-10	0.782
RPPA CNMF subtypes	5.91e-08	0.127	0.22	0.552	4.3e-06	0.149	5.29e-06	9.71e-08	0.332
RPPA cHierClus subtypes	1.06e-07	0.0772	0.336	0.0291	1.02e-07	0.252	0.000361	1.59e-07	0.1
RNAseq CNMF subtypes	2.59e-07	0.323	1.17e-05	0.709	1.37e-05	0.00986	0.000475	2.6e-06	1
RNAseq cHierClus subtypes	1.03e-09	0.335	0.00361	0.342	1.66e-10	0.00446	4.85e-05	7.47e-11	0.654
MIRseq CNMF subtypes	1.29e-06	0.0537	0.00265	0.149	0.00028	0.00693	0.000305	8.11e-05	0.53
MIRseq cHierClus subtypes	4.57e-06	0.0521	0.182	0.849	0.00064	0.00892	0.282	0.0143	0.123